Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care (Q45050933)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2004
edit
Language Label Description Also known as
English
Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care
scientific article published in October 2004

    Statements

    Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care (English)
    1 October 2004
    5 Suppl 1

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit